Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Amortizatization of Intangibles (2022 - 2025)

Stoke Therapeutics (STOK) has 4 years of Amortizatization of Intangibles data on record, last reported at -$615000.0 in Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles fell 12.43% year-over-year to -$615000.0; the TTM value through Sep 2025 reached -$1.4 million, down 43.73%, while the annual FY2024 figure was -$1.6 million, 405.23% down from the prior year.
  • Amortizatization of Intangibles reached -$615000.0 in Q3 2025 per STOK's latest filing, down from $527000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $527000.0 in Q2 2025 and bottomed at -$782000.0 in Q4 2024.
  • Average Amortizatization of Intangibles over 4 years is -$184000.0, with a median of -$146000.0 recorded in 2023.
  • The widest YoY moves for Amortizatization of Intangibles: up 282.35% in 2025, down 1958.33% in 2025.
  • A 4-year view of Amortizatization of Intangibles shows it stood at -$151000.0 in 2022, then surged by 41.06% to -$89000.0 in 2023, then crashed by 778.65% to -$782000.0 in 2024, then rose by 21.36% to -$615000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$615000.0 in Q3 2025, $527000.0 in Q2 2025, and -$494000.0 in Q1 2025.